Loncastuximab Tesirine-Lpyl Injection
15 interactions 19 cited referencesLoncastuximab tesirine-lpyl injection is used to treat a certain type of non-Hodgkin's lymphoma (NHL; a type of cancer that begins in a type of white blood cells that normally fights infection) that did not respond to or has returned after treatment with at least two other cancer treatments. Loncastuximab tesirine-lpyl… Read the full Loncastuximab Tesirine-Lpyl Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Loncastuximab Tesirine-Lpyl Injection Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Loncastuximab Tesirine-Lpyl Injection Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Loncastuximab Tesirine-Lpyl Injection Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Loncastuximab Tesirine-Lpyl Injection Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Loncastuximab Tesirine-Lpyl Injection Influenza Virus Vaccine, Live An increased risk of infection by the live vaccine Details Loncastuximab Tesirine-Lpyl Injection Rotavirus Vaccine, Live An increased risk of infection by the live vaccine DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist